‘Sharpshooter’ Cancer Drug Ready For Human Trials, Stops Cancer

 

 

 

 

” Cancer researchers from Toronto and Los Angeles combined research efforts and the result is a drug they call a “sharpshooter” for its ability to pinpoint enzymes and stop cancer, without harming healthy tissue. The drug is ready for human testing.

The Toronto group was lead by Dr. Tak Mak and the L.A group by Dr. Dennis Slamon and both researchers, and others from their teams, were on hand to announce the drug at a press conference in Toronto Tuesday.”